Objective Peroxisome injury occurs in the central nervous system (CNS) during multiple
virus infections that result in neurological disabilities. We investigated host neuroimmune …

Neurological complications that occur in SARS-CoV-2 infection, such as olfactory
dysfunction, brain inflammation, malaise, and depressive symptoms, are thought to …

In December 2019, a pneumonia outbreak was reported in Wuhan, Hubei province, China.
Since then, the World Health Organization declared a public health emergency of …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the
agent of novel coronavirus 2019 (COVID‐19), has kept the globe in disquiets due to its …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of
coronavirus disease 2019 (COVID-19), can induce a plethora of neurological complications …

Objective As SARS‐CoV‐2 is known to invade neural cell mitochondria, a plasma system for
quantifying central nervous system proteins in living humans was used to investigate …

In December 2019, a new viral disease emerged and quickly spread all around the world. In
March 2020, the COVID-19 outbreak was classified as a global pandemic and by June …

Background Neurological symptoms such as cognitive decline and depression contribute
substantially to post-COVID-19 syndrome, defined as lasting symptoms several weeks after …

Abstract Background Coronaviruses such as Severe Acute Respiratory Syndrome
coronavirus (SARS), Middle Eastern Respiratory Syndrome (MERS) and Severe Acute …

Background Although coronavirus disease 2019 (COVID‐19) has been associated primarily
with pneumonia, recent data show that the causative agent of COVID‐19, the coronavirus …